Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 8, 2011, Pages 3917-3921

  Hawser, Stephen P ^a   Bouchillon, Samuel K ^b   Lascols, Christine ^b   Hackel, Meredith ^b   Hoban, Daryl J ^b   Badal, Robert E ^b   Woodford, Neil ^c   Livermore, David M ^c  

^a International Health Management Associates Europe Sàrl   (Switzerland)

^b Division of Microbiology   (United States)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ABDOMINAL INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMIKACIN; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMIPENEM; INTRAABDOMINAL INFECTIONS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

EID: 79960325246     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00070-11     Document Type: Article

References (39)

1. Berne, T. V., A. W. Yellin, M. D. Appleman, and P. H. Heseltine. 1982. Antibiotic management of surgically treated gangrenous or perforated appendicitis: comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone. Am. J. Surg. 144:8-13.
2. Bratu, S., et al. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49:3018-3020.
3. Clinical and Laboratory Standards Institute. 2008. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th ed., document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing, document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing, document M100-S20-U. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Doumith, M., M. J. Ellington, D. M. Livermore, and N. Woodford. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63:659-667.
7. Ellington, M. J., J. Kistler, D. M. Livermore, and N. Woodford. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J. Antimicrob. Chemother. 59:321-322.
8. Endimiani, A., et al. 2009. Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J. Antimicrob. Chemother. 64:1102-1110.
9. Falagas, M. E., L. Barefoot, J. Griffith, R. Ruthazar, and D. R. Snydman. 1996. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur. J. Clin. Microbiol. Infect. Dis. 15:913-921.
10. Garcia-Fernandez, A., et al. 2010. An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob. Agents Chemother. 54:4178-4184.
11. Girlich, D., L. Poirel, and P. Nordmann. 2009. CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 53:832-834.
12. Hawser, S. P., S. K. Bouchillon, D. J. Hoban, and R. E. Badal. 2010. Epidemiologic trends, occurrence of extended-spectrum-beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study. Surg. Infect. 11:371-378.
13. Hawser, S. P., et al. 2010. Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob. Agents Chemother. 54:3043-3046.
14. Hirsch, E. B., and V. H. Tam. 2010. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J. Antimicrob. Chemother. 65:1119-1124.
15. Hoban, D. J., et al. 2010. Susceptibility of Gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob. Agents Chemother. 54:3031-3034.
16. Hsueh, P. R., et al. 2010. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int. J. Antimicrob. Agents 36:408-414.
17. Kirkland, K. B., J. P. Briggs, S. H. L. Trivette, W. E. Wilkinson, and D. J. Sexton. 1999. The impact of surgical site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect. Control Hosp. Epidemiol. 20:725-730.
18. Kumarasamy, K. K., et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological and epidemiological study. Lancet Infect. Dis. 10:597-602.
19. Livermore, D. M. 2002. The impact of carbapenemases on antimicrobial development and therapy. Curr. Opin. Invest. Drugs 3:218-224.
20. Livermore, D. M., et al. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.
21. Mosdell, D. M., D. M. Morris, and A. Voltura. 1991. Antibiotic treatment for surgical peritonitis. Ann. Surg. 214:543-549.
22. Mulvey, M. R., et al. 2004. Ambler class A extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48:1204-1214. (Pubitemid 38405474)
23. Navon-Venezia, S., et al. 2009. First report on hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob. Agents Chemother. 53:818-820.
24. Nordmann, P., G. Cuzon, and T. Naas. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236.
25. Nuesch-Inderbinen, M. T., H. Hachler, and F. H. Kayser. 1996. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis. 15:398-402.
26. Perez-Perez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
27. Pournaras, S., et al. 2009. Clonal spread of KPC-2 carbapenemase- producing Klebsiella pneumoniae strains in Greece. J. Antimicrob. Chemother. 64:348-352.
28. Pournaras, S., et al. 2010. Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae. J. Antimicrob. Chemother. 65:1604-1607.
29. Solomkin, J. S., E. P. Dellinger, N. V. Christou, and R. W. R. W. Busuttil. 1990. Results of a multicenter trial comparing imipenem/cilastin to tobramycin/clindamycin for intra-abdominal infections. Ann. Surg. 212:581-591.
30. Solomkin, J. S., et al. 2010. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin. Infect. Dis. 50:133-150.
31. Speldooren, V., B. Heym, R. Labia, and M. H. Nicolas-Chanoine. 1998. Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR. Antimicrob. Agents Chemother. 42:879-884.
32. Srinivasan, A., and J. B. Patel. 2008. Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure. Infect. Control Hosp. Epidemiol. 29:1107-1109.
33. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallobeta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
34. Wong, E. S. 1999. The price of a surgical site infection: more than just excess length of stay. Infect. Control Hosp. Epidemiol. 20:722-724.
35. Woodford, N., E. J. Fagan, and M. J. Ellington. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J. Antimicrob. Chemother. 57:154-155.
36. Woodford, N., et al. 2007. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 29:456-459.
37. Woodford, N., et al. 2008. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J. Antimicrob. Chemother. 62:1261-1264.
38. Yellin, A. E., P. N. Heseltine, and T. V. Berne. 1985. The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surg. Gynecol. Obstet. 161:303-307.
39. Yigit, H., et al. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161. (Pubitemid 32230996)